As of 2026-06-13, the EV/EBITDA ratio of Ironwood Pharmaceuticals Inc (IRWD) is 4.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IRWD's latest enterprise value is 965.21 mil USD. IRWD's TTM EBITDA according to its financial statements is 203.88 mil USD. Dividing these 2 quantities gives us the above IRWD EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 17.0x | 15.5x |
| Forward P/E multiples | 16.0x - 21.0x | 20.0x |
| Fair Price | 15.50 - 41.35 | 28.09 |
| Upside | 324.6% - 1033.0% | 669.7% |
| Date | EV/EBITDA |
| 2026-06-10 | 4.49 |
| 2026-06-09 | 4.39 |
| 2026-06-08 | 4.44 |
| 2026-06-05 | 4.46 |
| 2026-06-04 | 4.53 |
| 2026-06-03 | 4.40 |
| 2026-06-02 | 4.44 |
| 2026-06-01 | 4.58 |
| 2026-05-29 | 4.67 |
| 2026-05-28 | 4.69 |
| 2026-05-27 | 4.78 |
| 2026-05-26 | 4.94 |
| 2026-05-22 | 4.95 |
| 2026-05-21 | 4.90 |
| 2026-05-20 | 4.95 |
| 2026-05-19 | 4.75 |
| 2026-05-18 | 4.61 |
| 2026-05-15 | 4.68 |
| 2026-05-14 | 4.75 |
| 2026-05-13 | 4.76 |
| 2026-05-12 | 5.09 |
| 2026-05-11 | 5.15 |
| 2026-05-08 | 5.19 |
| 2026-05-07 | 5.15 |
| 2026-05-06 | 5.69 |
| 2026-05-05 | 5.56 |
| 2026-05-04 | 5.49 |
| 2026-05-01 | 5.37 |
| 2026-04-30 | 5.12 |
| 2026-04-29 | 5.14 |
| 2026-04-28 | 5.18 |
| 2026-04-27 | 5.05 |
| 2026-04-24 | 4.96 |
| 2026-04-23 | 4.85 |
| 2026-04-22 | 5.16 |
| 2026-04-21 | 5.07 |
| 2026-04-20 | 5.36 |
| 2026-04-17 | 5.36 |
| 2026-04-16 | 5.28 |
| 2026-04-15 | 5.32 |
| 2026-04-14 | 5.05 |
| 2026-04-13 | 4.73 |
| 2026-04-10 | 4.72 |
| 2026-04-09 | 4.69 |
| 2026-04-08 | 4.62 |
| 2026-04-07 | 4.58 |
| 2026-04-06 | 4.64 |
| 2026-04-02 | 4.65 |
| 2026-04-01 | 4.94 |
| 2026-03-31 | 4.62 |